Alyeska reports 9.9% Veru stake in ownership filing

Veru Inc. received a beneficial ownership report showing that Alyeska Investment Group, Alyeska Fund GP and Anand Parekh together hold 1,588,982 shares of Veru common stock, representing 9.9% of the outstanding class as of December 31, 2025.

Rhea-AI Filing Summary

Veru Inc. received a beneficial ownership report showing that Alyeska Investment Group, Alyeska Fund GP and Anand Parekh together hold 1,588,982 shares of Veru common stock, representing 9.9% of the outstanding class as of December 31, 2025. They report no sole voting or dispositive power, but shared voting and shared dispositive power over all reported shares.

An exhibit explains that the group owns 1,000,000 common shares and holds pre-funded warrants for 7,000,000 shares and additional warrants for 16,000,000 shares. These warrants are subject to a 9.9% beneficial ownership cap, so as of December 31, 2025 only 588,982 shares are counted from the warrants, bringing the total reported beneficial ownership to 1,588,982 shares. The percentage is based on 16,050,320 Veru shares outstanding from Veru’s Form 10-K.

The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Veru Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake in Veru (VERU) is reported by Alyeska and Anand Parekh?

They report beneficial ownership of 1,588,982 Veru common shares, equal to 9.9% of the outstanding class as of December 31, 2025, based on 16,050,320 shares outstanding from Veru’s latest Form 10-K filing.

How is the 9.9% beneficial ownership in Veru (VERU) calculated?

The 9.9% is calculated from 1,588,982 beneficially owned shares divided by 16,050,320 Veru shares outstanding, as disclosed in Veru’s Form 10-K filed December 17, 2025. This includes common shares plus exercisable warrant shares within a 9.9% cap.

What Veru (VERU) securities do the reporting persons actually hold?

They hold 1,000,000 common shares, pre-funded warrants to purchase 7,000,000 Veru shares, and warrants to purchase 16,000,000 shares. Due to the 9.9% beneficial ownership limitation, only 588,982 warrant shares are included in current beneficial ownership.

What is the 9.9% beneficial ownership limitation on Veru (VERU) warrants?

The warrants may only be exercised into a number of Veru shares that would result in at most 9.9% beneficial ownership. As of December 31, 2025, this restriction limits exercise to 588,982 shares being counted toward beneficial ownership.

Are Alyeska and Anand Parekh seeking control of Veru (VERU)?

They certify the Veru securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. They also state the holdings are not connected with any control-related transaction.

Who are the reporting persons in this Veru (VERU) Schedule 13G?

The reporting persons are Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh. All report shared voting and shared dispositive power over 1,588,982 Veru common shares, with no sole voting or dispositive authority indicated.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 04:57 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

VERU INC.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

92536C202

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 92536C202

1

Names of Reporting Persons

Alyeska Investment Group, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,588,982.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,588,982.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,588,982.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 92536C202

1

Names of Reporting Persons

Alyeska Fund GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,588,982.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,588,982.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,588,982.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 92536C202

1

Names of Reporting Persons

Anand Parekh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,588,982.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,588,982.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,588,982.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: VERU INC.
(b)	Address of issuer's principal executive offices: 2916 N. Miami Avenue, Suite 1000, Miami, Florida 33127
Item 2.
(a)	Name of person filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b)	Address or principal business office or, if none, residence: (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601
(c)	Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)	Title of class of securities: Common Stock, $0.01 par value per share
(e)	CUSIP No.: 92536C202
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,588,982
(b)	Percent of class: 9.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 1,588,982
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 1,588,982
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alyeska Investment Group, L.P.

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	02/17/2026

Alyeska Fund GP, LLC

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	02/17/2026

Anand Parekh

Signature:	Anand Parekh
Name/Title:	Anand Parekh | Self
Date:	02/17/2026

Exhibit Information

The reporting persons are the beneficial owners of 1,000,000 shares of common stock, hold pre-funded warrants to purchase 7,000,000 shares of the Issuer's Class A common stock, and hold warrants to purchase 16,000,000 shares of the Issuer's Class A common stock, (the "Warrants"). However, per their terms, the Warrants can only be exercised into such number of shares that would constitute 9.9% of the total number of Common Stock of the Issuer outstanding immediately after giving effect to the issuance of Common Stock upon exercise of this Warrant by the Holder. Accordingly, as of December 31, 2025 the reporting persons may only exercise up to 588,982 Ordinary Shares under the Warrant Agreement, and as such, is reporting beneficial ownership of only such number of shares. The percentage calculation assumes that there are currently 16,050,320 outstanding shares of Ordinary Shares of the Issuer, based on the Issuer's Form 10-K filed with the Securities and Exchange Commission on December 17, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.